Cargando…
Selective Serotonin Reuptake Inhibitor Pharmaco-Omics: Mechanisms and Prediction
Selective serotonin reuptake inhibitors (SSRIs) are a standard of care for the pharmacotherapy of patients suffering from Major Depressive Disorder (MDD). However, only one-half to two-thirds of MDD patients respond to SSRI therapy. Recently, a “multiple omics” research strategy was applied to ident...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836019/ https://www.ncbi.nlm.nih.gov/pubmed/33510640 http://dx.doi.org/10.3389/fphar.2020.614048 |